Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gaucher

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Blood|February 1, 1992
The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factorS Jorieux, E A Tuley, C Gaucher, et al.
Thrombosis and Haemostasis|August 1, 1996
Combined hereditary disorders of haemophilia B Leyden (-6 G-->A) and type 1 von Willebrand diseaseG Pernod, C Vinciguerra, C Gaucher, et al.
British Journal of Haematology|March 1, 1997
Rapid mutation screening in type 2A von Willebrand's disease using universal heteroduplex generatorsD Culpan, G Standen, N Wood, et al.
Clinical Hemorheology and Microcirculation|July 21, 2007
In vitro impact of physiological shear stress on endothelial cells gene expression profileC Gaucher, C Devaux, C Boura, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 27, 2015
[Diseases revealed by the mouth]S Opsahl-Vital, C Gaucher, C Bardet, et al.
British Journal of Haematology|December 19, 1998
Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578LeuL Hilbert, C Gaucher, J F Abgrall, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Expression in Escherichia coli of a recombinant fragment (Ile 914-Leu 1364) of human von Willebrand factor containing a collagen binding domainS Jorieux, G Piétu, C Gaucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
Natural gas of radiolytic origin: An overlooked component of shale gasMaria Naumenko-Dèzes, Wolfram Kloppmann, Michaela Blessing, et al.
Thrombosis and Haemostasis|April 1, 1995
Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factorC Gaucher, C de Romeuf, M Rauïs-Morret, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Blood|February 1, 1992
The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factorS Jorieux, E A Tuley, C Gaucher, et al.
Thrombosis and Haemostasis|August 1, 1996
Combined hereditary disorders of haemophilia B Leyden (-6 G-->A) and type 1 von Willebrand diseaseG Pernod, C Vinciguerra, C Gaucher, et al.
British Journal of Haematology|March 1, 1997
Rapid mutation screening in type 2A von Willebrand's disease using universal heteroduplex generatorsD Culpan, G Standen, N Wood, et al.
Clinical Hemorheology and Microcirculation|July 21, 2007
In vitro impact of physiological shear stress on endothelial cells gene expression profileC Gaucher, C Devaux, C Boura, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 27, 2015
[Diseases revealed by the mouth]S Opsahl-Vital, C Gaucher, C Bardet, et al.
British Journal of Haematology|December 19, 1998
Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578LeuL Hilbert, C Gaucher, J F Abgrall, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Expression in Escherichia coli of a recombinant fragment (Ile 914-Leu 1364) of human von Willebrand factor containing a collagen binding domainS Jorieux, G Piétu, C Gaucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
Natural gas of radiolytic origin: An overlooked component of shale gasMaria Naumenko-Dèzes, Wolfram Kloppmann, Michaela Blessing, et al.
Thrombosis and Haemostasis|April 1, 1995
Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factorC Gaucher, C de Romeuf, M Rauïs-Morret, et al.
Pageof 6